David Lowndes

David Lowndes has extensive work experience in the pharmaceutical industry. David is currently a Member of the Management Board at the Center for Breakthrough Medicines since 2023. Prior to this, they held various roles at SK pharmteco, including Chief Operating Officer and Member of the Board of Directors, where they supported customers worldwide in contract manufacturing and development. David also served as a Member of the Board of Directors at Yposkesi. David Lowndes founded DL Advisors LLC in 2021 and served as President until 2023. Previously, they held several senior leadership positions at Shire, including SVP Head Small Molecule Operating Unit and SVP Supply Chain Management. David also worked at Genzyme, Eli Lilly and Company, and Rhone Poulenc Rorer in various management roles. David Lowndes started their career at SPIMACO as a Production Manager.

David Lowndes obtained a BPharm degree in Pharmacy from the University of Wales Institute of Science and Technology between 1981 and 1984.